Urosepsis is a critical and life-threatening condition characterized by organ dysfunction resulting from a dysregulated host response to infections originating from the urinary tract or male genital organs. It accounts for 20–30% of global sepsis cases, with an estimated 10 million cases and 2 million deaths annually. The pathophysiology involves complex interactions between pro-inflammatory and anti-inflammatory responses, leading to significant morbidity and mortality. Early recognition and management are essential, with the Sepsis-3 guidelines recommending the Sequential Organ Failure Assessment (SOFA) score for diagnosis. Timely initiation of appropriate wide-spectrum antibiotic therapy within one hour of diagnosis is crucial for reducing mortality. Additionally, effective source control, which includes relieving urinary obstructions and draining abscesses, is fundamental to treatment. Supportive measures such as fluid resuscitation, corticosteroid administration, and early enteral nutrition are also vital in managing urosepsis. Recent studies emphasize the importance of early imaging to identify anatomical abnormalities that may contribute to urosepsis. Despite advancements in treatment protocols, urosepsis remains a significant challenge in healthcare, necessitating ongoing research and improved clinical practices to enhance patient care and outcomes. The integration of multidisciplinary approaches and adherence to established guidelines can further improve survival rates and reduce the burden of this serious condition.